Last reviewed · How we verify

NCT03417596

Vestibular Rehabilitation in Patients With Vestibular Migraine

Completed NA Last updated 31 January 2018
What this trial tests

NA trial testing Control in Vestibular Migraine in 77 participants. Completed in 15 April 2016.

Timeline
10 January 2015
Primary endpoint
10 April 2016
15 April 2016

Quick facts

Lead sponsorEge University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment77
Start date10 January 2015
Primary completion10 April 2016
Estimated completion15 April 2016

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

Eligibility, any sex, with Vestibular Migraine or Vestibular Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Abstract: Introduction: Vestibular migraine(VM) is a disease that manifests with episodic vertigo attacks in patients with or without migraine type headaches, when present accompanying the headaches. Its prevalence was found out as %1 in a study in Germany. It usually involves middle aged women. VM can make a huge impact on quality of life, therefore advances in its diagnosis and management are valuable. While pharmacotherapy that is being used in migraine can be beneficial, vestibular rehabilitation(VR) programmes are predicted to be one of the most important types of treatment in management of VM. This study compares the results of pharmacological management options and vestibular rehabilitation programmes in the context of dizziness, balance problems and headache. Material and methods: 77 patients with VM were included in study, and 60 of them completed it. While one group took only VR programme, and another took only pharmacological prophylaxis. The third group took a combined therapy, and the groups were consisted of 20 patients. Patients were assessed with caloric tests, audiometric studies, static posturography, Dizziness Handicap Inventory(DHI), and Activities Specific Balance Confidence(ABC) scales. All of the assessments were applied 3 times throughout the study, and the results were compared with relevant statistical tests.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Non-pharmacological interventions for prophylaxis of vestibular migraine.
    Webster KE, Dor A, Galbraith K, Haj Kassem L, et al · · 2023 · cited 12× · PMID 37042522 · DOI 10.1002/14651858.cd015321.pub2

Verify or expand the search:

Other trials of Control

Trials testing the same drug.

Other recruiting trials for Vestibular Migraine

Currently open trials in the same condition.

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03417596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing